Privia Health Group (NASDAQ:PRVA – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.02), Zacks reports. Privia Health Group had a return on equity of 2.02% and a net margin of 0.75%. Privia Health Group updated its FY 2025 guidance to EPS.
Privia Health Group Trading Up 5.8 %
PRVA traded up $1.40 during trading on Thursday, reaching $25.46. 1,667,006 shares of the company’s stock were exchanged, compared to its average volume of 650,137. Privia Health Group has a one year low of $15.92 and a one year high of $26.04. The stock has a market capitalization of $3.06 billion, a PE ratio of 254.63, a price-to-earnings-growth ratio of 3.47 and a beta of 0.87. The firm has a fifty day moving average price of $22.20 and a two-hundred day moving average price of $20.52.
Wall Street Analysts Forecast Growth
Several research firms have commented on PRVA. JPMorgan Chase & Co. raised their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Needham & Company LLC began coverage on shares of Privia Health Group in a report on Friday, January 10th. They issued a “buy” rating and a $25.00 target price on the stock. Macquarie began coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 target price on the stock. Barclays raised their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a report on Friday, November 8th. Finally, Stephens reissued an “overweight” rating and issued a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $25.19.
About Privia Health Group
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Further Reading
- Five stocks we like better than Privia Health Group
- Are Penny Stocks a Good Fit for Your Portfolio?
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- What is a Secondary Public Offering? What Investors Need to Know
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
